Follow the Beiersdorf Aktiengesellschaft stock price and the full insider trade history of the company, a listed equity based in Germany. Shares trade on DE DE, under the authority of BaFin. Operating in the Healthcare & Pharma sector, Beiersdorf Aktiengesellschaft has recorded 3 reports. Market capitalisation: €16.7bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: BBG Holding GmbH & Co. KG. All data is openly available.
Analysts rate Beiersdorf Aktiengesellschaft Buy (bullish), based on 19 analysts. Average price target: €86.63.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Beiersdorf Aktiengesellschaft is a leading German consumer and industrial group focused on skin care and adhesive solutions, listed on Xetra/Frankfurt (DAX/MDAX/SDAX) in Germany. The company traces its origins to Hamburg in the late nineteenth century, and Hamburg remains its headquarters to this day. Over time, Beiersdorf has built a reputation around one of the world’s most recognizable personal-care brands, NIVEA, alongside a broader portfolio that supports its global consumer franchise. The group’s business model is anchored in two main pillars. The first is the Consumer segment, which covers face care, body care, sun care, deodorants, lip care and wound care. Key brands include NIVEA, Eucerin, Aquaphor, Hansaplast and Labello. The second pillar is tesa, a wholly owned subgroup focused on innovative adhesive tapes and self-adhesive system solutions for industry, trades, and selected consumer applications. This structure gives Beiersdorf a mix of defensive branded consumer exposure and a more technical, B2B-oriented adhesives business. In competitive terms, Beiersdorf stands out through brand strength, dermatological expertise, product innovation and global distribution reach. NIVEA remains the group’s flagship mass-market brand and a major asset across multiple categories and geographies. Eucerin and Aquaphor strengthen Beiersdorf’s position in dermocosmetics, a category that has been performing well, while Hansaplast/Elastoplast supports a leading position in wound care and first aid. On the adhesives side, tesa provides diversification into industrial applications and higher-value engineered solutions. Beiersdorf operates globally across Europe, the Americas, Asia and other international markets, adapting formulations, launches and marketing to local consumer needs. Recent company communications in 2025 highlighted above-market growth in the Derma business, strong momentum in Health Care, and continued progress at tesa despite a slower market environment. The company also pointed to recent innovation-driven launches, including new NIVEA and Eucerin products in mainland China, and later adjusted its 2025 guidance to reflect softer market conditions in the second half. For investors, Beiersdorf offers a high-quality defensive profile, a strong brand portfolio, and exposure to both consumer health and industrial adhesives within a prominent German listed name on Xetra/Frankfurt.